Additionally, our previous studies demonstrated that Fyn is upregulated in BCR-ABL1 expressing CML cells and shRNA knockdown of Fyn leads to decreased growth of these cells [21]. The gene discussed is FYN; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.